Creative Planning Eye Point Pharmaceuticals, Inc. Transaction History
Creative Planning
- $116 Billion
- Q2 2025
A detailed history of Creative Planning transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Creative Planning holds 18,554 shares of EYPT stock, worth $231,368. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,554
Previous 20,895
11.2%
Holding current value
$231,368
Previous $113,000
53.98%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EYPT
# of Institutions
162Shares Held
67.2MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$104 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$84.8 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$84.8 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$57.4 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$53.6 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $425M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...